Ru-Yi Lai, Na Zheng, Ni-Na Peng, Li-le Li, Yu He, Yan Mei, Hong-Bo Wang
Affiliated Xiangyue Hospital of Hunan Institute of Parasitic Diseases, Yueyang 414000, China.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2017 May 17;29(5):648-650. doi: 10.16250/j.32.1374.2016260.
To investigate the clinical therapeutic effect of biological information infrared liver therapeutic apparatus (BILT) combined with praziquantel in the treatment of patients with chronic schistosomiasis.
A case-control study was conducted. A total of 142 chronic schistosomiasis patients were divided into an experimental group (BILT combined with praziquantel) with 64 cases and a control group (routine treatment with praziquantel alone) with 78 cases on the basis of the age, gender, disease duration and liver function as paired condition. Fatigue, diarrhea, abdominal distension, liver function, hyaluronic acid (HA) and laminin (LN) were as observation indexes and the observation results were compared between two groups.
Before the treatment, there were no significant differences between the two groups in the indexes above-mentioned ( > 0.05). After the treatment, the incidence rates of fatigue, diarrhea, abdominal distension, abnormal liver function, and the levels of HA and LN in the experimental group were significantly lower than those in the control group ( < 0.01).
BILT combined with praziquantel can significantly alleviate the short-term clinical symptoms, restore liver function and also alleviate hepatic fibrosis of the patients with chronic schistosomiasis.